
- Identification
- Properties
- Safety Data
- Specifications & Other Information
- Links
- Quick Inquiry
Identification
CAS Number
606143-52-6
Name
Selumetinib CAS 606143-52-6
Synonyms
1H-Benzimidazole-6-carboxamide, 5--4-fluoro-N-(2-hydroxyethoxy)-1-methyl- 5--4-fluor-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazol-6-carboxamid 5--4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide5--4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide 5--4-fluoro-N-(2-hydroxyéthoxy)-1-méthyl-1H-benzimidazole-6-carboxamide 606143-52-6 6UH91I579Uselumetinib selumetinib sélumétinib selumetinibum 1777807-55-2 1H-Benzimidazole-6-carboxamide, 5--4-fluoro-N-(2-hydroxyethoxy)-1-methyl3EW5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzoimidazole-6-carboxamide5-(4-Bromo-2-chlorophenylamino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzoimidazole-6-carboxamide6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-5-benzimidazolecarboxamide6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide6-(4-Bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide6-(4-Bromo-2-chlorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzoimidazole-5-carboxamide6--7-fluoro-N-(2-hydroxyethoxy)-3-methyl-5-benzimidazolecarboxamide6--7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide6--7-fluoro-N-(2-hydroxyethoxy)-3-methyl-benzimidazole-5-carboxamideArray142886AZD6244, ARRY-142886, ARRY-886CHEMBL1614701D09666MAP2K1MFCD11977472 sélumétinibSelumetinib (USAN/INN)selumetinibumUNII:6UH91I579UUNII-6UH91I579Uселуметиниб
SMILES
Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3Cl)Br)C(=O)NOCCO
StdInChI
InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
StdInChIKey
CYOHGALHFOKKQC-UHFFFAOYSA-N
Molecular Formula
C17H15BrClFN4O3
Molecular Weight
457.681
EINECS
207-313-3
MDL Number
MFCD11977472
Properties
Appearance
White or off-white powder.
Safety Data
Symbol
GHS07, GHS08
Signal Word
Warning
Hazard statements
H302 - H317 - H361f - H373 - H413
Precautionary Statements
P202 - P273 - P280 - P301 + P312 - P302 + P352 - P308 + P313
WGK Germany
3
MSDS Download
Specifications and Other Information of Our
Identification Methods
Purity
99% min
Water
0.5%max
RESIDUE ON IGNITION
0.2 %max
Ethyl acetate
≤5000ppm
Methanol
≤5000ppm
Dichloromethane
≤600ppm
THF
≤500ppm
Petroleum ether
≤5000ppm
Shelf Life
2 years
Storage
Under room temperature away from light
Known Application
Selumetinib CAS 606143-52-6 is used for the treatment of advanced non-small cell lung cancer (NSCLC). Selumetinib primarily inhibits the growth of various tumors, including melanomas with B-Raf mutations and non-small cell lung cancer (NSCLC) with K-Ras mutations, by regulating the key protein kinase MEK in the Ras-Raf-MEK-ERK pathway. It is mainly employed in the treatment of diseases such as cholangiocarcinoma, colorectal cancer, and NSCLC. Currently, Selumetinib is in phase III clinical trials for the treatment of non-small cell lung cancer.
General View of Documents
Links
This product is developed by our R&D company Caming Pharmaceutical Limited (http://www.caming.com/).
Quick Inquiry
Fill out our inquiry form and one of our experts will be in touch with you shortly.
https://www.watson-int.com/selumetinib-cas-606143-52-6/
Comments
Post a Comment